Browse By Region

Browse By Category
Recent News
By Category: Research
Synthetic biology research community grows significantly
(ScienceDaily) he number of private and public entities conducting research in synthetic biology worldwide grew significantly between 2009 and 2013, according to the latest version of an interactive map produced by the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars.
- May 1, 2013
- | Filed under North America, Biotechnology, and Research
Mutant bird-flu H5N1 virus evolves to show pandemic traits
(BusinessMirror) A mutant version of a bird-flu virus created by scientists last year to show its ability to spread between humans evolved to show characteristics of previous pandemic viruses, a study found.
- April 29, 2013
- | Filed under North America and Research
GAO-13-249, Toxic Substances: EPA Has Increased Efforts to Assess and Control Chemicals but Could Strengthen Its Approach, March 22, 2013
Since 2009, the Environmental Protection Agency (EPA) has made progress implementing its new approach to managing toxic chemicals under its existing Toxic Substances Control Act (TSCA) authority; particularly by increasing efforts to obtain chemical toxicity and exposure data and initiating chemical risk assessments–which EPA uses, along with other information, to decide what regulatory or other Read More »
- April 29, 2013
- | Filed under Research
Mutant version of H5N1 flu virus found to be more preferential to human infection
(MedicalXpress) An international team of bio-researchers has found that a mutant strain of the H5N1 influenza virus (created in a lab) has a 200-fold preference for binding with receptors in human cells, over those found in birds. In describing their research and conclusions in their paper published in the journal Nature, the researchers suggest that Read More »
- April 26, 2013
- | Filed under North America and Research
Clues to making vaccine for infant respiratory illness
(ScienceDaily) An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common — and sometimes very serious — childhood disease. The findings, by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, Read More »
- April 26, 2013
- | Filed under North America and Research